Showing results (1731-1740 of 2,064) with videos related to

Sort By:
Pageof 207
Brachytherapy|February 8, 2011
Impact of urinary catheterization on dosimetry after prostate implant brachytherapy with palladium-103 or iodine-125Shervin M Shirvani, Rajat J Kudchadker, Teresa L Bruno, et al.
Brachytherapy|June 21, 2011
Long-term results of 1-week intravaginal high-dose-rate brachytherapy alone for endometrial cancerMiren Gaztañaga, Mauricio Cambeiro, Elena Villafranca, et al.
Brachytherapy|October 26, 2007
Androgen deprivation-mediated cytoreduction before interstitial brachytherapy for prostate cancer does not abrogate the elevated risk of urinary morbidity associated with larger initial prostate volumeJoshua H Petit, Clifford Gluck, W S Kiger, et al.
Brachytherapy|October 26, 2007
Interstitial brachytherapy for soft tissue sarcoma: A single institution experienceMichelle L Mierzwa, Connie M McCluskey, William L Barrett, et al.
Brachytherapy|October 30, 2007
Computed tomography-ultrasound fusion brachytherapy: description and evolution of the techniqueDonald B Fuller, Haoran Jin
Brachytherapy|November 23, 2011
Tumor bed-to-skin distance using accelerated partial-breast irradiation with the strut-adjusted volume implant deviceBrandon Fisher, Larry Daugherty, Talha Shaikh, et al.
Brachytherapy|May 1, 2012
High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literaturePaul L Nguyen, Phillip M Devlin, Clair J Beard, et al.
Brachytherapy|February 15, 2012
Impact of MRI-based postimplant dosimetric assessment in prostate brachytherapy using contrast-enhanced T1-weighted imagesToshio Ohashi, Tetsuo Momma, Shoji Yamashita, et al.
Brachytherapy|March 23, 2012
Long-term outcome for very high-risk prostate cancer treated primarily with a triple modality approach to include permanent interstitial brachytherapyNathan Bittner, Gregory S Merrick, Wayne M Butler, et al.
Brachytherapy|March 23, 2012
Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanomaDaniel Grossi Marconi, Douglas Guedes de Castro, Lievin Matos Rebouças, et al.
Pageof 207